Global NGS data analysis market is anticipated to reach USD 2.03 billion by 2024, according to a new report by Grand View Research, Inc. Growth in next generation sequencing and data analysis market is driven by rise in adoption of laboratory management system (LIMS) in order to safeguard theobtained raw structure using downstream analyses.
Demand for the data solutions that ensure provision of complete traceability of the workflow implemented during interpretation are expected to boost R&D in this market thereby leading to growth through to 2024. Additionally, ongoing research endeavors for monitoring and standardization of data flowwith respect to input and output directories, even with multiple evaluation protocols being used on the same data, are anticipated to fuel progress in the coming years.
In order to reduce the turnaround time for analysis, software modularity is being implemented using parallel computation pertaining to cloud computing and multicore processors, which in turn is attributive to fuel revenue generation.
View summary of this report @ http://www.grandviewresearch.com/industry-analysis/next-generation-sequencing-ngs-data-analysis-market
Further key findings from the report suggest:
·
Platform OS/UI accounted for the revenue share
of over 52% because of the cost associated with the design of platforms used in
storage and management of vast amount of sequence information obtained from
high throughput sequencers. Moreover, running the analysis on graphical user
interface based softwares and connecting it with command-line interfaces that
are implemented on Linux/Unix operating systems requires substantial research thus
leading to growth in this range of products.
·
Tertiary data analysis dominates the market
space in context to market revenue as a result of the presence of several
state-of-the art tools useful for variant annotation and application specific
biological interpretation of sequence information. Furthermore, introduction of
tools that use Python modulesand enable Unix command-lineusers to execute
projects on the supported pipelines, that can be debugged and corrected through
built-in version controls.
·
In-house sequence interpretation accounted for
the larger share of market revenue due to the presence of high budget
allocation by the companies involved, for installation of algorithmictools and
purchase of licensed softwares. Moreover, the research entities are following
the trend of outsourcing data interpretation services to subsidiary branches
and their own bioinformatics departments that even though technically
constitutes outsourcing, consequently ends up adding to the in-house data
analysis revenue.
·
Higher usage of NGS in academic institutes and
university based research centers for the purpose of fellowship projects is
supportive for the largest share of academic end-users in NGS data
interpretation market. Furthermore, rising implementation of NGS in disease
diagnosis and etiology study is expected to boost revenue generation through to
2024.
·
North America held the largest share in 2015,
accounting for about46% of total revenue.Presenceof key participants operating
in biotechnology as well as information technology sector in this region
aresupportive for the estimated revenue share of the region.
·
Asia Pacific is estimated to witnessthe fastest
growth over the forecast period owing to the rising usage of novel platforms
and solutions in the developing economies of this region. Moreover, provision
of these services by the prominent players in economies of this region has
poised this region to exhibit potentially high value avenues and opportunities
for growth over the forecast period.
·
Key players operating in this industry
includeIllumina Inc., Congenica, Ingenuity, Omicia, Inc. Station X, Inc.,
WuXiNextCODE, DNAnexus, SevenBridges Genomics, Bluebee, Genalice, and Edico
Genome.
·
In addition to the established companies, there
is significant impact of open source tools for sequence analysisin the form of
standalone solutions or in combination with commercialproducts
Browse
more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology
Grand View Research has segmented NGS data analysis software storage & management market on the basis of product, mode, workflow, end use and region:
Global NGS Data Analysis Software Storage & Management Market Outlook, by Product (Revenue, USD Million, 2013 - 2024)
·
Services
·
NGS Commercial Software
o
Platform OS/UI
o
Analytical Software
§ QC/Pre-processing
Tools
§ Alignment
Tools & Software
§ DNA
Seq Alignment
§ RNA
Seq Alignment
§ Protein
Seq Alignment
§ Others
Global NGS Data Analysis Software Storage & Management Outlook,
by Workflow (Revenue, USD Million, 2013 - 2024)
·
Primary Data Analysis
·
Secondary Data Analysis
o
Read Mapping
o
Variant Alignment & Variant Calling
·
Tertiary Data Analysis
o
Variant Annotation
o
Application Specific Data Analysis
o
Targeted bi-sulfite/ Methylation
o
Exome/Targeted DNA
o
RNA seq
o
Whole genome
o
Chip Seq
o
Others
Global NGS Data Analysis Software Storage & Management Outlook,
by Mode (Revenue, USD Million, 2013 - 2024)
·
In-house Data Analysis
·
Outsourced Data Analysis
Global NGS Data Analysis Software Storage & Management Outlook,
by End-use (Revenue, USD Million, 2013 - 2024)
·
Academic Research
·
Clinical Research
·
Hospitals & Clinics
·
Pharma & Biotech Entities
·
Other users
Global NGS Data Analysis Software Storage & Management Market
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
UK
·
Asia Pacific
o
China
o
Japan
·
Latin America
o
Brazil
·
MEA
o
South Africa
For press release of this report - http://www.grandviewresearch.com/press-release/global-next-generation-sequencing-ngs-data-analysis-market
About Grand View
Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, the
company offers market intelligence studies ensuring relevant and fact-based
research across a range of industries including technology, chemicals,
materials, healthcare and energy.
Contact:
Sherry
James
Corporate
Sales Specialist, U.S.A.
Grand
View Research, Inc.
United
States
Phone: 1-415-349-0058
Toll
Free: 1-888-202-9519
Email: sales@grandviewresearch.com
No comments:
Post a Comment